Hypertrophic cardiomyopathy is the most common genetic heart disease. Biomarkers,
molecules measurable in the blood, could inform the clinician by aiding in diagnosis …

Cardiac troponin I (cTnI), the inhibitory-unit, and cardiac troponin T (cTnT), the tropomyosin-
binding unit together with the Ca-binding unit (cTnC) of the hetero-trimeric troponin complex …

While predicting prognosis to anticipate adverse disease course has long been an
aspiration in hypertrophic cardiomyopathy (HC), reliable markers of progressive and …

Background Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy
(DMD), but studies suggest heart failure biomarkers correlate poorly with cardiomyopathy …

Монографію присвячено питанням стимуляції фізичної та психічної працездатності в
динаміці процесу підготовки спортсменів з урахуванням принципів і методологій …

Background: Human immunodeficiency virus (HIV) is mainly detected in young, otherwise
healthy, individuals. Cardiomyopathy and peripheral artery disease affecting these patients …

BACKGROUND: Serum troponins and CK-MB (creatine kinase-MB) are readily detectable
and reliable cardiac-specific biomarkers of subclinical myocardial injury. This study explores …

Diffusion-weighted imaging (DWI) has been confirmed to be associated with late gadolinium
enhancement (LGE) in hypertrophic cardiomyopathy (HCM). In this context, we aimed to …

The aim of this study was to assess the significance of post-operative troponin levels as a
surrogate for left ventricular (LV) dysfunction measured by global longitudinal strain (GLS) in …

The association between global and segmental myocardial strain impairment and fibrosis
extent in hypertrophic cardiomyopathy (HCM) is widely verified. The aim of this study was to …